Marshall Wace

Marshall Wace’s Savara SVRA Stock Holding History

Marshall Wace’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.6M	Sell	4,514,348 -45,573	-1%	-$254K	0.03%	624
2025 Q4	$27.5M	Buy	+4,559,921	New	+$22.3M	0.03%	530
2025 Q1	–	Sell	-361,229	Closed	-$1.11M	–	3098
2024 Q4	$1.11M	Buy	+361,229	New	+$1.26M	﹤0.01%	1688
2024 Q3	–	Sell	-304,700	Closed	-$1.23M	–	2970
2024 Q2	$1.23M	Buy	304,700 +246,107	+420%	+$1.09M	﹤0.01%	1597
2024 Q1	$292K	Buy	+58,593	New	+$283K	﹤0.01%	2124
2023 Q2	–	Sell	-33,333	Closed	-$65K	–	3011
2023 Q1	$65K	Buy	+33,333	New	+$75.1K	﹤0.01%	2527
2020 Q1	–	Sell	-36,570	Closed	-$164K	–	2047
2019 Q4	$164K	Buy	+36,570	New	+$44K	﹤0.01%	1386

Other funds holding SVRA

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return